首页> 外文OA文献 >Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.
【2h】

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.

机译:重新评估知情同意的方法:成人地中海贫血患者不相关造血干细胞移植的情况。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: The informed consent process is the legal embodiment of the fundamental right of the individual to make decisions affecting his or her health., and the patient's permission is a crucial form of respect of freedom and dignity, it becomes extremely important to enhance the patient's understanding and recall of the information given by the physician. This statement acquires additional weight when the medical treatment proposed can potentially be detrimental or even fatal. This is the case of thalassemia patients pertaining to class 3 of the Pesaro classification where Allogenic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative treatment. Unfortunately, this kind of intervention is burdened by an elevated transplantation-related mortality risk (TRM: all deaths considered related to transplantation), equal to 30% according to published reports. In thalassemia, the role of the patient in the informed consent process leading up to HSCT has not been fully investigated. This study investigated the hypothesis that information provided by physicians in the medical scenario of HSCT is not fully understood by patients and that misunderstanding and communication biases may affect the clinical decision-making process. METHODS: A questionnaire was either mailed or given personally to 25 patients. A second questionnaire was administered to the 12 physicians attending the patients enrolled in this study. Descriptive statistics were used to evaluate the communication factors. RESULTS: The results pointed out the difference between the risks communicated by physicians and the risks perceived by patients. Besides the study highlighted the mortality risk considered to be acceptable by patients and that considered to be acceptable by physicians. CONCLUSIONS: Several solutions have been suggested to reduce the gap between communicated and perceived data. A multi-disciplinary approach may possibly help to attenuate some aspects of communication bias. Several tools have also been proposed to fill or to attenuate the gap between communicated and perceived data. But the most important tool is the ability of the physician to comprehend the right place of conscious consent in the relationship with the patient.
机译:简介:知情同意程序是个人做出影响其健康的决定的基本权利的法律体现。患者的许可是尊重自由和尊严的重要形式,提高患者的尊严至关重要了解和回顾医师提供的信息。当所提议的药物治疗可能有害甚至致命时,这种说法就会增加体重。这是属于Pesaro分类第3类的地中海贫血患者的情况,其中同种异体造血干细胞移植(HSCT)仍然是唯一可能治愈的疗法。不幸的是,根据已发布的报告,这种干预措施会增加与移植相关的死亡风险(TRM:被认为与移植有关的所有死亡),这是增加的负担。在地中海贫血中,尚未充分调查患者在导致HSCT的知情同意过程中的作用。这项研究调查了以下假设:患者并未完全理解HSCT医疗场景中医师提供的信息,误解和沟通偏见可能会影响临床决策过程。方法:向25位患者邮寄或亲自寄出问卷。向参加本研究的患者的12位医生发放了第二份问卷。描述性统计用于评估沟通因素。结果:结果指出了医生传达的风险与患者感知的风险之间的差异。此外,研究还强调了患者认为可以接受的死亡风险以及医生认为可以接受的死亡风险。结论:提出了几种解决方案,以减少沟通和感知数据之间的差距。多学科方法可能有助于减轻沟通偏见的某些方面。还提出了几种工具来填补或减弱通信数据和感知数据之间的差距。但是最重​​要的工具是医师理解与患者关系中知情同意的正确位置的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号